Donghui Cui
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Advanced Photocatalysis Techniques, Sleep and Wakefulness Research, Sleep and related disorders, Drug Transport and Resistance Mechanisms
Most-Cited Works
- → Discovery of the Dual Orexin Receptor Antagonist [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia(2010)370 cited
- → Metabolism and Disposition in Humans of Raltegravir (MK-0518), an Anti-AIDS Drug Targeting the Human Immunodeficiency Virus 1 Integrase Enzyme(2007)274 cited
- → Promotion of Sleep by Suvorexant—A Novel Dual Orexin Receptor Antagonist(2011)270 cited
- → Drug–Drug Interaction Studies: Regulatory Guidance and An Industry Perspective(2013)240 cited
- → Metabolism and Disposition of Dasatinib after Oral Administration to Humans(2008)194 cited
- → Pharmacokinetic Drug Interactions Involving 17??-Ethinylestradiol(2007)171 cited
- → Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions(2000)123 cited
- → Pharmacological characterization of MK-6096 – A dual orexin receptor antagonist for insomnia(2011)123 cited
- → Discovery of [(2R,5R)‐5‐{[(5‐Fluoropyridin‐2‐yl)oxy]methyl}‐2‐methylpiperidin‐1‐yl][5‐methyl‐2‐(pyrimidin‐2‐yl)phenyl]methanone (MK‐6096): A Dual Orexin Receptor Antagonist with Potent Sleep‐Promoting Properties(2012)121 cited
- → Metabolites of Caspofungin Acetate, a Potent Antifungal Agent, in Human Plasma and Urine(2000)102 cited